DEA - DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy' | Benzinga
The Drug Enforcement Administration (DEA) is actively seeking to dispel any illusions that its process for drug scheduling, in this case for cannabis, is opaque. An official said that the agency wants to correct “misperceptions” that it is functioning in secrecy, for which it has been roundly accused.
In a conversation on the DEA’s podcast series “Prevention Profiles: Take Five,” Rich Lucey, the senior prevention program manager, spoke with DEA pharmacologist Buki Ebeigbe about the marijuana scheduling process, reported Marijuana Moment's Kyle Jaeger on Thursday. This is the first-ever public discourse on the agency’s analysis of marijuana's Schedule I classification.
“I just think it's important for people to—again, going back to correcting misperceptions and really the issue of transparency and, by us even doing this podcast, just to help people understand the process,” Lucey said. “We don't want it to necessarily feel as if it's behind this shroud of secrecy, which I think then lends itself to this idea that it's a whole arbitrary process.”
The DEA’s silence beyond acknowledging the receipt of the U.S. Department of Health ...